
PubMed:10421786
Annnotations
jnlpba-st-training
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-19 | protein | denotes | STAT5 |
T2 | 23-27 | protein | denotes | IL-4 |
T3 | 38-50 | protein | denotes | Janus kinase |
T4 | 225-230 | protein | denotes | STAT5 |
T5 | 254-273 | protein | denotes | human IL-4 receptor |
T6 | 275-280 | protein | denotes | IL-4R |
T7 | 310-326 | protein | denotes | receptor mutants |
T8 | 334-356 | cell_line | denotes | murine pro-B cell line |
T9 | 357-362 | cell_line | denotes | Ba/F3 |
T10 | 427-444 | protein | denotes | IL-4R alpha chain |
T11 | 465-469 | protein | denotes | IL-4 |
T12 | 478-483 | protein | denotes | STAT5 |
T13 | 519-564 | protein | denotes | membrane-proximal proline-rich sequence motif |
T14 | 567-571 | protein | denotes | box1 |
T15 | 599-614 | protein | denotes | bipartite IL-4R |
T16 | 677-690 | protein | denotes | Janus kinases |
T17 | 691-695 | protein | denotes | JAK1 |
T18 | 700-704 | protein | denotes | JAK3 |
T19 | 715-719 | protein | denotes | IL-4 |
T20 | 744-749 | protein | denotes | STAT5 |
T21 | 788-813 | protein | denotes | dominant-negative version |
T22 | 817-823 | protein | denotes | STAT5b |
T23 | 836-842 | protein | denotes | STAT5a |
T24 | 860-864 | protein | denotes | IL-4 |
T25 | 890-901 | cell_line | denotes | Ba/F3 cells |
T26 | 932-938 | protein | denotes | STAT5b |
T27 | 984-989 | protein | denotes | IL-4R |
T28 | 1069-1074 | protein | denotes | STAT5 |
T29 | 1142-1146 | protein | denotes | IL-4 |
T30 | 1162-1168 | protein | denotes | STAT5a |
T31 | 1173-1179 | protein | denotes | STAT5b |
T32 | 1198-1202 | protein | denotes | IL-4 |
GENIAcorpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-19 | protein_molecule | denotes | STAT5 |
T2 | 23-27 | protein_molecule | denotes | IL-4 |
T3 | 38-50 | protein_family_or_group | denotes | Janus kinase |
T4 | 71-79 | other_name | denotes | receptor |
T5 | 80-88 | amino_acid_monomer | denotes | tyrosine |
T6 | 133-151 | other_name | denotes | cell proliferation |
T7 | 156-171 | other_name | denotes | gene regulation |
T8 | 225-230 | protein_molecule | denotes | STAT5 |
T9 | 254-259 | protein_molecule | denotes | human |
T10 | 260-264 | protein_molecule | denotes | IL-4 |
T11 | 275-280 | protein_molecule | denotes | IL-4R |
T12 | 310-326 | protein_family_or_group | denotes | receptor mutants |
T13 | 334-356 | cell_line | denotes | murine pro-B cell line |
T14 | 357-362 | cell_line | denotes | Ba/F3 |
T15 | 383-397 | amino_acid_monomer | denotes | phosphorylated |
T16 | 398-406 | amino_acid_monomer | denotes | tyrosine |
T17 | 427-444 | protein_subunit | denotes | IL-4R alpha chain |
T18 | 465-469 | protein_molecule | denotes | IL-4 |
T19 | 478-483 | protein_molecule | denotes | STAT5 |
T20 | 599-614 | protein_molecule | denotes | bipartite IL-4R |
T21 | 634-648 | other_name | denotes | ligand-induced |
T22 | 649-657 | amino_acid_monomer | denotes | tyrosine |
T23 | 677-690 | protein_family_or_group | denotes | Janus kinases |
T24 | 691-695 | protein_molecule | denotes | JAK1 |
T25 | 700-704 | protein_molecule | denotes | JAK3 |
T26 | 715-719 | protein_molecule | denotes | IL-4 |
T27 | 744-749 | protein_molecule | denotes | STAT5 |
T28 | 754-765 | other_name | denotes | concomitant |
T29 | 766-784 | other_name | denotes | cell proliferation |
T30 | 788-813 | protein_family_or_group | denotes | dominant-negative version |
T31 | 817-823 | protein_molecule | denotes | STAT5b |
T32 | 836-842 | protein_molecule | denotes | STAT5a |
T33 | 860-864 | protein_molecule | denotes | IL-4 |
T34 | 890-901 | cell_line | denotes | Ba/F3 cells |
T35 | 932-938 | protein_molecule | denotes | STAT5b |
T36 | 957-975 | other_name | denotes | cell proliferation |
T37 | 984-989 | protein_molecule | denotes | IL-4R |
T38 | 1069-1074 | protein_molecule | denotes | STAT5 |
T39 | 1142-1146 | protein_molecule | denotes | IL-4 |
T40 | 1162-1168 | protein_molecule | denotes | STAT5a |
T41 | 1173-1179 | protein_molecule | denotes | STAT5b |
T42 | 1198-1202 | protein_molecule | denotes | IL-4 |
genia-medco-coref
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
C1 | 14-19 | NP | denotes | STAT5 |
C3 | 0-19 | NP | denotes | Activation of STAT5 |
C2 | 23-27 | NP | denotes | IL-4 |
C4 | 225-241 | NP | denotes | STAT5 activation |
C12 | 250-281 | NP | denotes | the human IL-4 receptor (IL-4R) |
C5 | 465-470 | NP | denotes | IL-4- |
C6 | 715-720 | NP | denotes | IL-4- |
C7 | 744-749 | NP | denotes | STAT5 |
C9 | 817-823 | NP | denotes | STAT5b |
C15 | 836-842 | NP | denotes | STAT5a |
C8 | 860-865 | NP | denotes | IL-4- |
C10 | 932-938 | NP | denotes | STAT5b |
C11 | 984-989 | NP | denotes | IL-4R |
C13 | 1142-1146 | NP | denotes | IL-4 |
C14 | 1162-1168 | NP | denotes | STAT5a |
C16 | 1173-1179 | NP | denotes | STAT5b |
R1 | C4 | C3 | coref-ident | STAT5 activation,Activation of STAT5 |
R2 | C5 | C2 | coref-ident | IL-4-,IL-4 |
R3 | C6 | C5 | coref-ident | IL-4-,IL-4- |
R4 | C7 | C1 | coref-ident | STAT5,STAT5 |
R5 | C8 | C6 | coref-ident | IL-4-,IL-4- |
R6 | C10 | C9 | coref-ident | STAT5b,STAT5b |
R7 | C11 | C12 | coref-ident | IL-4R,the human IL-4 receptor (IL-4R) |
R8 | C13 | C8 | coref-ident | IL-4,IL-4- |
R9 | C14 | C15 | coref-ident | STAT5a,STAT5a |
R10 | C16 | C10 | coref-ident | STAT5b,STAT5b |
pubmed-sentences-benchmark
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
S1 | 0-172 | Sentence | denotes | Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation. |
S2 | 173-282 | Sentence | denotes | We have investigated mechanisms and consequences of STAT5 activation through the human IL-4 receptor (IL-4R). |
S3 | 283-493 | Sentence | denotes | By functionally expressing receptor mutants in the murine pro-B cell line Ba/F3, we could show that phosphorylated tyrosine residues within the IL-4R alpha chain are dispensable for IL-4-induced STAT5 activity. |
S4 | 494-785 | Sentence | denotes | However, disruption of a membrane-proximal proline-rich sequence motif ('box1') in either subunit of the bipartite IL-4R abolished not only ligand-induced tyrosine phosphorylation of Janus kinases JAK1 and JAK3, but also IL-4-triggered activation of STAT5 and concomitant cell proliferation. |
S5 | 786-990 | Sentence | denotes | A dominant-negative version of STAT5b, but not of STAT5a, interfered with IL-4-induced DNA synthesis in Ba/F3 cells, suggesting an involvement of STAT5b in the control of cell proliferation through IL-4R. |
S6 | 991-1237 | Sentence | denotes | Reporter gene experiments finally showed that transcription from promoters of STAT5 target genes can be specifically induced by challenging cells with IL-4, and that both STAT5a and STAT5b can contribute to IL-4-triggered transcriptional control. |